Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23, a Known Phosphaturic Agent

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

June 30, 2010

Study Completion Date

August 31, 2011

Conditions
Growth Disorders
Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

University of Alabama at Birmingham

OTHER